Drug Approval | June 09, 2026
FDA expands Pfizer’s HYMPAVZI approval
Broadening access for children & patients with inhibitor-complicated hemophilia
Broadening access for children & patients with inhibitor-complicated hemophilia
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
